Ukutya kwe-T Cell Precursor Acute Lymphoblastic Leukemia!

intshayelelo

Ukutya kwe-T Cell Precursor Acute Lymphoblastic Leukemia kufuneka ilungiselelwe umntu ngamnye kwaye kufuneka ilungelelanise xa unyango lomhlaza okanye utshintsho lwemfuzo yethumba. Ukwenziwa komntu kunye nokulungelelaniswa kufuneka kuthathelwe ingqalelo zonke izithako ezisebenzayo okanye i-bioactives equlethwe kukutya okwahlukeneyo malunga nebhayoloji yethishu yomhlaza, imfuzo, unyango, iimeko zokuphila kunye nokukhethwa kokutya. Kungoko ngexa isondlo sesinye sezigqibo ezibaluleke kakhulu kwisigulana somhlaza kunye nomntu osemngciphekweni wokuba nomhlaza – ukukhetha ukutya oza kukutya akuyondlwan’ iyanetha.

Kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia ingaba ibalulekile ukuba yeyiphi imifuno, iziqhamo, amandongomane, imbewu umntu ayityayo?

Umbuzo oxhaphake kakhulu ngesondlo obubuzwa zizigulane ezinomhlaza kunye nabantu abakumngcipheko wemfuzo womhlaza ngowomhlaza - wezomhlaza ezifana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia ingaba ayinamsebenzi ukuba kukuphi ukutya endikutyayo kwaye ndingakwenzi? Okanye ukuba ndilandela ukutya okusekwe kwisityalo oko kwanela umhlaza ofana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia?

Umzekelo ingaba inomsebenzi ukuba imifuno yaseNew Zealand isipinatshi ityiwa kakhulu xa ithelekiswa neChayote? Ngaba kuyawenza umahluko xa kukhethwa isiqhamo iPitanga kuneFrench Plantain? Kwakhona ukuba ukhetho olufanayo lwenziwa kwiindongomane/iimbewu ezifana neButternut ngaphezu kweChestnut yaseYurophu kunye neempumlo ezifana neembotyi eziBanzi phezu kweBean eYellow Wax. Kwaye ukuba into endiyityayo ibalulekile - umntu ukuchonga njani ukutya okucetyiswayo kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia kwaye ingaba impendulo efanayo kuye wonke umntu onoxilongo olufanayo okanye umngcipheko wemfuzo?

Ewe! Ukutya okutyayo kubalulekile kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia!

Iingcebiso zokutya zisenokungafani kumntu wonke kwaye zinokwahluka nakwisifo esifanayo kunye nomngcipheko wemfuzo.

Konke ukutya (imifuno, iziqhamo, amandongomane, iimbewu, i-pulses, i-oyile njl.njl.) kunye nezongezo zesondlo zenziwe ngaphezu kwesinye isithako esisebenzayo semolekyuli okanye i-bio-actives ngokwemilinganiselo eyahlukeneyo kunye nezixa. Isithako ngasinye esisebenzayo sinendlela ekhethekileyo yokusebenza - enokuthi isebenze okanye ithintele iindlela ezahlukeneyo ze-biochemical. Ukutya okuchazwe ngokulula kunye nezongezo ezicetyiswayo zezo zingabangeli ukwanda kwabaqhubi beemolekyuli zomhlaza kodwa zibanciphise. Okanye oko kutya akufuneki kunconywe. Ukutya kuqulethe izithako ezininzi ezisebenzayo - kungoko xa uvavanya ukutya kunye nezongezelelo kufuneka uqwalasele ifuthe lazo zonke izithako ezisebenzayo ngokongezelekayo kunomntu ngamnye.

Umzekelo i-Pitanga iqulethe izithako ezisebenzayo i-Myricetin, i-Apigenin, i-Isoliquiritigenin, i-Quercetin, i-Luteolin. Kwaye iPlantain yesiFrentshi iqulethe izithako ezisebenzayo iMyricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Quercetin kwaye mhlawumbi nabanye.

Impazamo eqhelekileyo eyenziwa xa kusenziwa isigqibo nokukhetha ukutya okufuneka kutyiwe kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia - kukuvavanya kuphela izithako ezisebenzayo ezikhethiweyo eziqulethwe kukutya kwaye ungayihoyi intsalela. Ngenxa yokuba izithako ezahlukeneyo ezisebenzayo eziqulethwe kukutya zinokuba neziphumo ezichasayo kubaqhubi bomhlaza - awukwazi ukukhetha izithako ezisebenzayo ekutyeni kunye nezongezelelo ukwenza isigqibo sesondlo se-Early T Cell Precursor Acute Lymphoblastic Leukemia.

EWE – UKHETHO LOKUTYA LUYINGABA NOMHLAZA. IZIGQIBO ZOKUTYA KUFUNEKA IZIQWELELE ZONKE IZINTO EZISEBENZAYO ZOKUTYA.

Izakhono ezifunekayo kuMntu weSondlo kwiSeli yeT yaKwangoko I-Acute Lymphoblastic Leukemia?

Isondlo somntu somhlaza esifana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia ibandakanya ukutya okucetyiswayo / izongezo; ukutya okungacetyiswanga / izongezo ezinomzekelo weeresiphi ezibeka phambili ukusetyenziswa kokutya okucetyiswayo. Umzekelo wesondlo somntu unokubonwa koku ikhonkco.

Ukugqiba ukuba kukuphi ukutya okucetyiswayo okanye okungacetyiswayo kuntsonkothile kakhulu, kufuna ubuchwephesha kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia biology, isayensi yokutya, i-genetics, i-biochemistry kunye nokuqonda kakuhle indlela unyango lomhlaza olusebenza ngayo kunye nokuba sesichengeni okuhambelana nonyango olunokuthi luyeke ukusebenza.

UBUCHULE OBUBONA ULWAZI OLUFUNEKAYO UKUZE SONDLWE UMNTU WOMHLAZA ZI: IBHALOJI YOMHLAZA, ISAYENSI YOKUTYA, UNYANGO LOMHLAZA KUNYE NEMFUZO.

Iimpawu zomhlaza ezifana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia

Yonke imihlaza efana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia inokuphawulwa ngoluhlu olulodwa lweendlela ze-biochemical - iindlela zokutyikitya ze-Early T Cell Precursor Acute Lymphoblastic Leukemia. Iindlela ze-Biochemical ezifana ne-Apoptosis, i-RAS-RAF Signaling, i-JAK-STAT Signaling, i-Notch Signaling iyingxenye yenkcazo yesignesha ye-Early T Cell Precursor Acute Lymphoblastic Leukemia. Imfuzo yomhlaza yomntu ngamnye inokwahluka kwaye kungoko utyikityo lwabo lomhlaza lunokwahluka.

Unyango olusebenzayo kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia kufuneka luthathele ingqalelo utyikityo olunxulumene neendlela zebhayokhemikhali kwisigulana somhlaza ngamnye kunye nomntu osengozini yemfuzo. Ngoko ke unyango oluhlukeneyo ngeendlela ezahlukeneyo zezenzo zisebenza kakuhle kwizigulane ezahlukeneyo. Ngokufanayo kwaye ngenxa yezizathu ezifanayo ukutya kunye nezongezo kufuneka zenziwe kumntu ngamnye. Yiyo loo nto okunye ukutya kunye nezongezo zicetyiswayo kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa uthatha unyango lomhlaza iNelarabine, kwaye okunye ukutya kunye nezongezo azikhuthazwa.

Imithombo efana cBioPortal kunye nabanye abaninzi banikezela ngedatha emele isigulana esingaziwa kulingo lwezonyango kuzo zonke iimpawu zomhlaza. Le datha iqulathe iinkcukacha zophononongo lwezonyango ezifana nobungakanani besampulu / inani lezigulana, amaqela obudala, isini, ubuhlanga, unyango, indawo yethumba kunye naluphi na utshintsho lwemfuza.

I-NOTCH1, JAK1, CDK12, MMP24 kunye ne-TCF7L2 zezona ziphezulu iiseli ezixeliweyo ze-Early T Cell Precursor Acute Lymphoblastic Leukemia. I-NOTCH1 ixelwe kwi-83.3% yezigulane ezimele kuzo zonke iimvavanyo zekliniki. Kwaye i-JAK1 ixelwe kwi-50.0%. Idatha yezigulane ezidityanisiweyo igubungela iminyaka yobudala ukusuka kwi-3 ukuya kuma-20. I-83.3 % yedatha yesigulane ichongwa njengamadoda. I-Early T Cell Precursor Acute Lymphoblastic Leukemia biology kunye ne-genetics exeliweyo kunye zichaza inani labantu elimelwe utyikityo lweendlela zebhayoloji kulo mhlaza. Ukuba ithumba lomhlaza lomntu ngamnye lifuzo okanye imfuza enegalelo kumngcipheko nayo iyaziwa ke leyo kufuneka isetyenziselwe ukwenziwa kwesondlo.

UKHETHO LWESONDLO MELE LUHAMBANE NOMNTU NGAMNYE WOMNTU WOMNTU.

Ukutya kunye nezongezelelo zeT Cell Precursor Acute Lymphoblastic Leukemia

Kwizigulane zoMhlaza

Izigulana zomhlaza ezikunyango okanye kukhathalelo lokuthomalalisa kufuneka zenze izigqibo ngokutya kunye nezongezelelo - kwiikhalori ezifunekayo zokutya, ukulawula naziphi na iziphumo ebezingalindelekanga zonyango kunye nokuphuculwa kolawulo lomhlaza. Konke ukutya okusekelwe kwizityalo akulingani kwaye ukukhetha kunye nokubeka phambili ukutya okwenziwa ngumntu kwaye kulungiselelwe unyango oluqhubekayo lomhlaza kubalulekile kwaye kunzima. Nantsi eminye imizekelo ebonelela ngezikhokelo zokwenza izigqibo zesondlo.

Khetha imifuno NEW ZEALAND SPINACH okanye CHAYOTE?

Imifuno yaseNew Zealand Isipinatshi iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Myricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Quercetin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-RAS-RAF Signaling, i-JAK-STAT Signaling, i-PI3K-AKT-MTOR yokuSayina kunye ne-MAPK yokuSayina kunye nabanye. I-New Zealand Spinach icetyiswa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo i-Nelarabine. Oku kungenxa yokuba isipinatshi saseNew Zealand siguqula ezo ndlela zebhayomichimi eziye zaxelwa ngokwesayensi ukwazisa isiphumo seNelarabine.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwi-Chayote yemifuno yiMyricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Luteolin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-MAPK Signaling, i-PI3K-AKT-MTOR Ukubonakaliswa, i-Oncogenic Cancer Epigenetics kunye ne-Suppressive Histone Methylation kunye nabanye. I-Chayote ayikhuthazwa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo i-Nelarabine kuba luguqula ezo ndlela ze-biochemical ezenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli.

IMIFUNO ENTSHA ZEALAND ISIPINACH IYANCEBISWA PHEZU KWE-CHAYOTE NGE-Early T Cell Precursor Acute Lymphoblastic Leukemia KUNYE NONYANGO iNelarabine.

Khetha iFruit FRENCH PLANTAIN okanye iPITANGA?

Isiqhamo sePlantain yesiFrentshi sinezithako ezininzi ezisebenzayo okanye i-bioactives efana neMyricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Quercetin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-RAS-RAF Signaling, i-JAK-STAT Signaling, i-PI3K-AKT-MTOR yokuSayina kunye ne-MAPK yokuSayina kunye nabanye. IFrench Plantain icetyiswa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo yiNelarabine. Oku kungenxa yokuba i-French Plantain iguqula ezo ndlela ze-biochemical eziye zaxelwa ngokwesayensi ukwazisa umphumo we-Nelarabine.

Ezinye zezithako ezisebenzayo okanye i-bioactives kwisiqhamo i-Pitanga yiMyricetin, i-Apigenin, i-Isoliquiritigenin, i-Quercetin, i-Luteolin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Oncogenic Cancer Epigenetics, i-Suppressive Histone Methylation kunye ne-Apoptosis kunye nabanye. I-Pitanga ayikhuthazwa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo i-Nelarabine kuba luguqula ezo ndlela ze-biochemical ezenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli ngokukhawuleza.

IFRUIT FRENCH PLANTAIN IYAKUCEBISWA NGAPHEZU KWE-PITANGA YE-Early T Cell Precursor Acute Lymphoblastic Leukemia KUNYE NONYANGO iNelarabine.

Khetha Nut BUTTERNUT okanye EUROPEAN CHESTNUT?

I-Butternut iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Myricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Luteolin. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-RAS-RAF Signaling, i-JAK-STAT Signaling, i-PI3K-AKT-MTOR yokuSayina kunye ne-MAPK yokuSayina kunye nabanye. I-Butternut iyacetyiswa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo i-Nelarabine. Oku kungenxa yokuba i-Butternut iguqula ezo ndlela ze-biochemical eziye zaxelwa ngokwesayensi ukuze zikhuthaze umphumo we-Nelarabine.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwi-Chestnut yaseYurophu yiMyricetin, i-Apigenin, i-Isoliquiritigenin, i-Kaempferol, i-Quercetin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Oncogenic Cancer Epigenetics, i-Noncoding RNA Signaling kunye ne-Apoptosis kunye nezinye. I-Chestnut yaseYurophu ayikhuthazwa kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia xa unyango lomhlaza oluqhubekayo i-Nelarabine kuba luguqula ezo ndlela ze-biochemical ezenza ukuba unyango lomhlaza luxhathise okanye lungaphenduli ngokukhawuleza.

IBHUTTERNUT KUCEBISWA NGAPHEZU KWE-EUROPEY CHESTNUT FOR Early T Cell Precursor Acute Lymphoblastic Leukemia KUNYE NONYANGO Nelarabine.

Kubantu ngabanye abaneMngcipheko yeGenetic yoMhlaza

Umbuzo obuzwe ngabantu abasengozini yemfuza ye-Early T Cell Precursor Acute Lymphoblastic Leukemia okanye imbali yentsapho ithi "Yintoni endimele ndiyitye ngokwahlukileyo kunangaphambili?" kunye nendlela ekufuneka bakhethe ngayo ukutya kunye nezongezo zokulawula imingcipheko yesi sifo. Kuba kumngcipheko womhlaza akukho nto inokwenzeka malunga nonyango - izigqibo zokutya kunye nezongezo zibalulekile kwaye yenye yezinto ezimbalwa ezinokuthi zenziwe. Konke ukutya okusekelwe kwizityalo akulingani kwaye kusekelwe kwi-genetics echongiweyo kunye nendlela yokutyikitya - ukhetho lokutya kunye nezongezelelo kufuneka lube lolwakho.

Khetha Imifuno EQHELEKILEYO IKHOWA okanye iJUTE?

I-Vegetable Common Mushroom iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Curcumin, i-Apigenin, i-Formononetin, i-Lupeol, i-Eugenol. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Extracellular Matrix Remodelling, i-JAK-STAT Signaling, i-Inflammation kunye ne-Apoptosis kunye nabanye. I-Common Mushroom icetyiswa kumngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa ingozi yemfuzo enxulumeneyo yi-CDK12. Oku kungenxa yokuba i-Mushroom eqhelekileyo yonyusa ezo ndlela zebhayoloji ezichasene nabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwimifuno yeJute yi-Quercetin, i-Curcumin, i-Apigenin, i-Formononetin, i-Lupeol. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Interferon Signaling kunye nezinye. I-Jute ayikhuthazwa xa umngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa umngcipheko wezofuzo unxulumene ne-CDK12 kuba yonyusa iindlela zokutyikitya kuyo.

IKHOWA ELIQHELEKILEYO LOMFUNO KUCEBISWA NGAPHEZU KWEJUTE NGE-CDK12 GENETIC RISK YOMHLAZA.

Khetha iSiqhamo RABBITEYE BLUEBERRY okanye UMHLA?

I-Fruit Rabbiteye Blueberry iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana ne-Quercetin, i-Eugenol, i-Linalool, i-Ferulic Acid, i-Epicatechin. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Extracellular Matrix Remodelling, i-Apoptosis kunye ne-MYC Signaling kunye nezinye. I-Rabbiteye Blueberry icetyiswa kumngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa umngcipheko wemfuzo ohambelana ne-CDK12. Oku kungenxa yokuba iRabbiteye Blueberry yonyusa ezo ndlela zebhayoloji ezichasene nabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwisiqhamo Umhla yi-Curcumin, i-Apigenin, i-Formononetin, i-Lupeol, i-Eugenol. Ezi zithako ezisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-IL10 Umqondiso kunye ne-Interferon Signaling kunye nabanye. Umhla awukhuthazwa xa umngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa umngcipheko wezofuzo unxulumene ne-CDK12 kuba yonyusa iindlela zokutyikitya kuyo.

FRUIT RABBITEYE BLUEBERRY KUCEBISWA NGEMHLA NGECDK12 genetic RISK YOMHLAZA.

Khetha Nut IMBEWU YAMANANGA okanye MACADAMIA NUT?

Imbewu yethanga iqulethe izithako ezininzi ezisebenzayo okanye i-bioactives efana neCucurbitacin I, i-Stigmasterol, i-Beta-sitosterol, i-Linolenic Acid, i-Salicylic Acid. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Extracellular Matrix Remodelling, i-JAK-STAT yokuSayina, i-Notch Signaling kunye ne-IL10 Signaling kunye nabanye. Imbewu yethanga icetyiswa kumngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa umngcipheko wemfuzo ohambelana ne-CDK12. Oku kungenxa yokuba Imbewu yethanga yonyusa ezo pathways biochemical ezichasa utyikityo lwabaqhubi bayo.

Ezinye zezinto ezisebenzayo okanye i-bioactives kwi-Macadamia Nut yi-Curcumin, i-Apigenin, i-Formononetin, i-Lupeol, i-Eugenol. Ezi zithako zisebenzayo zilawula iindlela ezahlukeneyo ze-biochemical ezifana ne-Interferon Signaling kunye ne-MYC Signaling kunye nezinye. I-Macadamia Nut ayikhuthazwa xa umngcipheko we-Early T Cell Precursor Acute Lymphoblastic Leukemia xa umngcipheko wezofuzo unxulumene ne-CDK12 kuba yonyusa iindlela zokutyikitya kuyo.

IMBEWU YAMATHANGO IYAKUNIKEZISWA NGE-MACADAMIA NUT NGE-CDK12 GENETIC RISK YOMHLAZA.

Ukuququmbela

Ukutya kunye nezongezo ezikhethiweyo zizigqibo ezibalulekileyo zomhlaza ezifana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia. I-Early T Cell Precursor i-Acute Lymphoblastic Leukemia izigulane kunye nabantu abasengozini yemfuza bahlala benalo mbuzo: "Kukuphi ukutya kunye nezongezo zesondlo ezicetyiswayo kum kwaye ezingekho?" Kukho inkolelo eqhelekileyo eyingcamango ephosakeleyo yokuba konke ukutya okusekelwe kwizityalo kunokuba luncedo okanye akunjalo kodwa akuyi kuba yingozi. Ukutya okuthile kunye nezongezelelo zinokuphazamisana nonyango lomhlaza okanye zikhuthaze abaqhubi beendlela zeemolekyuli zomhlaza.

Kukho iintlobo ezahlukeneyo zezalathisi zomhlaza ezifana ne-Early T Cell Precursor Acute Lymphoblastic Leukemia, nganye ineemfuza ezahlukeneyo zethumba ezinolunye utshintsho lwe-genomic kumntu ngamnye. Ngaphaya koko, lonke unyango lomhlaza kunye nechemotherapy linendlela eyodwa yokusebenza. Ukutya ngakunye okufana nesipinatshi saseNew Zealand kuqulethe izinto ezahlukeneyo zebhayoloji kwimiyinge eyahlukeneyo, enempembelelo kwiiseti ezahlukeneyo kunye nezahlukileyo zeendlela zebhayoloji. Inkcazo yesondlo somntu siqu zingcebiso zokutya zomntu ngamnye kwisalathiso somhlaza, unyango, imfuzo, indlela yokuphila kunye nezinye izinto. Izigqibo zokwenziwa kwesondlo kumhlaza zifuna ulwazi lwebhayoloji yomhlaza, isayensi yokutya kunye nokuqonda iindlela ezahlukeneyo zonyango lwechemotherapy. Ekugqibeleni xa kukho utshintsho lonyango okanye i-genomics entsha ichongiwe - isondlo somntu sidinga ukuphononongwa kwakhona.

Isisombululo se-addon sesondlo somntu senza ukuba isigqibo sibe lula kwaye sisuse yonke into eqikelelwayo ekuphenduleni umbuzo, "Kukuphi ukutya endimele ndikukhethe okanye ndingakhethi kwi-Early T Cell Precursor Acute Lymphoblastic Leukemia?". Iqela le-addon multi-disciplinary libandakanya oogqirha bomhlaza, izazinzulu zeklinikhi, iinjineli zesoftware kunye nososayensi bedatha.

Ucaphulo

• Pptc 2019
• Ukuchazwa kweGenomic yeeModeli ze-Xenograft zeSigulana ezithathwe kwiSigulana sokuNxibelela ukuVumela uYilo oluQhelekileyo loLwango lweKlinikhi.
• I-lipidomics esebenzayo: I-Palmitic acid iphazamisa uphuhliso lwe-hepatocellular carcinoma ngokumodareyitha ulwelo lwe-membrane kunye ne-glucose metabolism.
• Ukufunyanwa kwee-flavones ezincinci ezingaziwa njenge-inhibitors ye-NF-κB yokubonisa kwi-MDA-MB-231 iiseli zomhlaza webele-Isifundo se-SAR.
• I-Curcumin inqanda ukukhula ngendlela ye-Wnt / β-catenin kwiiseli zomhlaza wemiphunga ezingezizo ezincinci.
• I-Epicatechin ivuselela umsebenzi we-mitochondrial kwaye ikhetha ngokukhetha iiseli zomhlaza kwimitha.
• I-asidi ye-Gallic inqanda ukufuduka kunye nokuhlasela kwiiseli ze-osteosarcoma ze-U-2 ze-OS ngokucinezela i-matrix metalloproteinase-2/-9, iprotein kinase B (PKB) kunye ne-PKC yokubonisa iindlela.
• I-Gamma linolenic acid icinezela i-hypoxia-induced gastric cancer cell growth kunye ne-epithelial-mesenchymal transition ngokuthintela indlela yokubonisa i-Wnt / b-catenin.
• I-Cucurbitacin I inqanda ukufuduka kweeseli kunye nokuhlasela kwaye iphakamisa i-chemosensitivity kumhlaza wekoloni.